Literature DB >> 6123990

Antral gastrin and somatostatin concentrations in peptic ulcer patients.

K Sumii, T Fukushima, K Hirata, Y Matsumoto, E Sanuki, S Tsumaru, M Sumioka, A Miyoshi, Y Miyachi.   

Abstract

As an attempt to approach the pathogenesis of peptic ulcer disease, antral gastrin and somatostatin concentrations were studied in normal subjects, patients with duodenal ulcer and gastric ulcer. In the patients with peptic ulcer, antral somatostatin concentrations were significantly lower than those in normal subjects. In non-ulcer subjects, including normal subjects and patients with atrophic gastritis, antral somatostatin concentrations were correlated inversely with the degree of antral gastritis, while in the patients with peptic ulcer, especially in duodenal ulcer, they were low, irrespective of histological picture of antral mucosa. In the patients with duodenal ulcer, low antral somatostatin concentrations with high antral gastrin/somatostatin ratio may cause increased serum gastrin levels and increased gastric acid secretion. From the above findings, it has been concluded that low antral somatostatin levels may be related to the pathogenesis of duodenal ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6123990     DOI: 10.1016/0196-9781(81)90046-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

1.  Effects of pirenzepine on omeprazole-induced gastrin gene expression in rat antral tissues.

Authors:  A Tari; M Hamada; T Kamiyasu; Y Fukino; M Sumii; K Sumii; G Kajiyama
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Acid-sensitive and alkaline-sensitive sensory neurons regulate pH dependent gastrin secretion in rat.

Authors:  K Nojima; K Sumii; M Sumii; S Okahara; K Haruma; M Yoshihara; G Kajiyama
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 3.  The significance of gastrin in the pathogenesis and therapy of peptic ulcer disease.

Authors:  C B Lamers
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Effect of systemic gastric acid stimulation and intragastric pH changes on synchronous antral gastrin and somatostatin release in anesthetized, nonatropinized duodenal ulcer patients and controls.

Authors:  Z Ferahköşe; H Altinyollar; B B Menteş
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

5.  Somatostatin in gastric juice in normal subjects and patients with duodenal ulcer.

Authors:  K Sumii; M Sumioka; M Yoshihara; A Tari; K Haruma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

6.  Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.

Authors:  T J Colturi; R H Unger; M Feldman
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Sample taking problems in measuring actual histamine levels of human gastroduodenal mucosa: specific and general relevance in clinical trials on peptic ulcer pathogenesis and selective proximal vagotomy.

Authors:  K P Thon; W Lorenz; C Ohmann; D Weber; H Rohde; H D Röher
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

8.  Significance of an exaggerated meal-stimulated gastrin response in pathogenesis of Helicobacter pylori-negative duodenal ulcer.

Authors:  Tomoari Kamada; Ken Haruma; Hiroaki Kusunoki; Masaki Miyamoto; Masanori Ito; Yasuhiko Kitadai; Masaharu Yoshihara; Kazuaki Chayama; Kazumasa Tahara; Yuzuru Kawamura
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

9.  Effects of pirenzepine on omeprazole-induced hypergastrinemia and acid suppression in peptic ulcer patients.

Authors:  A Tari; M Hamada; T Kamiyasu; Y Fukino; M Sumii; K Haruma; K Sumii; M Inoue; G Kajiyama
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

10.  Antral release of gastrin and somatostatin in duodenal ulcer and control subjects.

Authors:  R F Harty; D G Maico; J E McGuigan
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.